Cargando…

Efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome

Clinical efficacy of pulmonary surfactant combined with high-dose ambroxol hydrochloride in the treatment of neonatal respiratory distress syndrome (NRDS) was investigated. One hundred child patients with NRDS in Linyi Central Hospital were collected according to the diagnostic criteria for RDS in t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Jiajun, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566082/ https://www.ncbi.nlm.nih.gov/pubmed/31258703 http://dx.doi.org/10.3892/etm.2019.7615

Ejemplares similares

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Effect of different ventilation methods combined with pulmonary surfactant on neonatal acute respiratory distress syndrome
por: Qing, Qing, et al.
Publicado: (2023)

RP-HPLC and Spectrophotometric Estimation of Ambroxol Hydrochloride and Cetirizine Hydrochloride in Combined Dosage Form
por: Bhatia, Neela M., et al.
Publicado: (2008)

Different ventilation modes combined with ambroxol in the treatment of respiratory distress syndrome in premature infants
por: Zhou, Bin, et al.
Publicado: (2017)

Efficacy study of pulmonary surfactant combined with assisted ventilation for acute respiratory distress syndrome management of term neonates
por: Liu, Jinfeng, et al.
Publicado: (2017)

Continuous positive pressure ventilation combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Miao, Jing, et al.
Publicado: (2020)

Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole
por: Li, Xiuyun, et al.
Publicado: (2017)

Ambroxol hydrochloride in the management of idiopathic pulmonary fibrosis: Clinical trials are the need of the hour
por: Gupta, P. R.
Publicado: (2014)

History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
por: Bae, Chong-Woo, et al.
Publicado: (2019)

The effect of high-frequency oscillatory ventilator combined with pulmonary surfactant in the treatment of neonatal respiratory distress syndrome
por: Wang, Tie-Yan, et al.
Publicado: (2022)

Efficacy of Ambroxol Hydrochloride Combined with Amoxicillin Potassium Clavulanate Combination on Children with Bronchopneumonia and Its Impact on the Level of Inflammatory Factors
por: Zhu, Xiaoli, et al.
Publicado: (2022)

Preparation and Evaluation of Microencapsulated Fast Melt Tablets of Ambroxol Hydrochloride
por: Jacob, S., et al.
Publicado: (2009)

Simultaneous UV Spectrophotometric Estimation of Ambroxol Hydrochloride and Levocetirizine Dihydrochloride
por: Prabhu, S. Lakshmana, et al.
Publicado: (2008)

Retracted: Efficacy of Ambroxol Hydrochloride Combined with Amoxicillin Potassium Clavulanate Combination on Children with Bronchopneumonia and Its Impact on the Level of Inflammatory Factors
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Clinical effects of pulmonary surfactant in combination with nasal continuous positive airway pressure therapy on neonatal respiratory distress syndrome
por: Zhang, Congmin, et al.
Publicado: (2017)

Meta-analysis of the efficacy of budesonide and ambroxol hydrochloride inhalation in children with pneumonia and their effects on inflammatory response
por: Shen, Huanan, et al.
Publicado: (2023)

Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea
por: Shin, Jeong Eun, et al.
Publicado: (2020)

Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?
por: Kumar, Pradeep
Publicado: (2020)

Efficacy and safety of ambroxol hydrochloride in the treatment of secretory otitis media: a systematic review and meta-analysis
por: Zhou, Xufeng, et al.
Publicado: (2022)

The Role of Surfactant in Respiratory Distress Syndrome
por: Ma, Christopher Cheng-Hwa, et al.
Publicado: (2012)

Biodegradable Chitosan-Based Ambroxol Hydrochloride Microspheres: Effect of Cross-Linking Agents
por: Gangurde, HH, et al.
Publicado: (2011)

Turkish Neonatal Society guideline on the management of respiratory distress syndrome and surfactant treatment
por: Özkan, Hasan, et al.
Publicado: (2018)

Comparison of the efficacy of two natural surfactants (BERAKSURF and BLES) in the treatment of respiratory distress syndrome among preterm neonates
por: Sabzevari, Fatemeh, et al.
Publicado: (2023)

Prehospital administration of surfactant to a premature neonate in respiratory distress
por: Mize, Charles Haviland, et al.
Publicado: (2019)

Irrational prescription of surfactant replacement therapy in neonatal respiratory distress
por: Jahanmehr, Nader, et al.
Publicado: (2022)

Target product profile: aerosolized surfactant for neonatal respiratory distress
por: Rao, Suman, et al.
Publicado: (2023)

Gender-related efficacy of pulmonary surfactant in infants with respiratory distress syndrome: A STROBE compliant study
por: Chen, Chen, et al.
Publicado: (2018)

Aerosol Delivery of Lung Surfactant and Nasal CPAP in the Treatment of Neonatal Respiratory Distress Syndrome
por: Walther, Frans J., et al.
Publicado: (2022)

Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease —research or clinical application?
por: Greenough, Anne
Publicado: (1995)

The Role of Pulmonary Surfactants in the Treatment of Acute Respiratory Distress Syndrome in COVID-19
por: Wang, Shengguang, et al.
Publicado: (2021)

Profound Effect of Pulmonary Surfactant on the Treatment of Preterm Infants with Respiratory Distress Syndrome
por: Liu, Lin, et al.
Publicado: (2022)

Efficacy and safety of surfactant administration by MIST and INSURE techniques in Neonates with Respiratory Distress Syndrome: A randomized controlled trial
por: Kaleem, Ammara, et al.
Publicado: (2023)

The application of ambroxol hydrochloride combined with fiberoptic bronchoscopy in elderly patients with severe pneumonia: A meta-analysis and systematic review
por: Tang, Haowei, et al.
Publicado: (2022)

Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis
por: Qiu, Caihong, et al.
Publicado: (2020)

Effects of the expectorant drug ambroxol hydrochloride on chemically induced lung inflammatory and neoplastic lesions in rodents
por: Yoshida, Shota, et al.
Publicado: (2018)

Effects of Bronchoalveolar Lavage with Ambroxol Hydrochloride on Treating Pulmonary Infection in Patients with Cerebral Infarction and on Serum Proinflammatory Cytokines, MDA and SOD
por: Meng, Fanhua, et al.
Publicado: (2020)

Animal-derived surfactants for the treatment and prevention of neonatal respiratory distress syndrome: summary of clinical trials
por: Logan, J Wells, et al.
Publicado: (2009)

Correlation between surfactant protein B mRNA expression and neonatal respiratory distress syndrome
por: YIN, XIAOJUAN, et al.
Publicado: (2012)

Surfactant alteration and replacement in acute respiratory distress syndrome
por: Günther, Andreas, et al.
Publicado: (2001)

Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
por: Brasher, Mandy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fbghn4dms990d53a0pnj93aeeu